Discover
Find people to follow: investors with a track record, rising voices and verified creators.
People into Biotech (new drugs)
Nobody to show here yet.
Browse by theme
- All themes
- K-pop & entertainment
- K-drama & film
- Webtoons & content
- Games
- K-beauty
- K-food & ramen
- Airlines & travel
- Casinos
- Retail & duty-free
- Pet care
- Sports & leisure
- Education & edtech
- AI software & services
- Data centers
- HBM & AI chips
- Semiconductor equipment & materials
- Chip testing & packaging
- Foundry & chip design
- Glass substrates
- AI power & transformers
- Robots & humanoids
- On-device AI
- Displays
- Internet platforms
- Fintech & payments
- Quantum technology
- Cybersecurity
- Software & cloud
- Smartphone parts
- Telecom & 5G
- AR, VR & XR
- EV batteries
- Battery materials (cathode, anode, lithium)
- Nuclear power & SMR
- Hydrogen
- Solar & wind
- Power grid & cables
- Energy storage (ESS)
- Oil, refining & chemicals
- LNG & gas
- Lithium & rare metals
- Shipbuilding
- K-defense
- Space & aerospace
- Construction & Middle East projects
- Steel
- Zinc & non-ferrous metals
- Machinery & heavy equipment
- Shipping & logistics
- Railways
- Value-up (low P/B, shareholder returns)
- Banks
- Insurance
- Holding companies
- Securities firms
- High dividends
- REITs
- Crypto & digital assets
- Biotech (new drugs)
- Biosimilars
- Contract drug manufacturing (CDMO)
- Obesity drugs
- Aesthetics & botox
- Medical devices
- AI healthcare
- ADC & cancer drugs
- Pharmaceuticals
- Hyundai & Kia (carmakers)
- EV parts
- Self-driving
- Flying taxis (UAM)
- Tires
- North Korea & reunification
- China consumer
- US tariffs & exports
- Weak won, strong exporters
- Ageing & low birth rate
- Climate & carbon credits